Imidazole Lactate
Imidazole lactate is an organic acid and a metabolite derived from the amino acid histidine. Its presence and concentration in biological fluids, particularly serum, are part of the broader field of metabolomics, which aims for a comprehensive measurement of endogenous metabolites to provide a functional readout of an individual’s physiological state[1]. Understanding the levels of such metabolites can offer insights into the complex interplay between genetics, environment, and health.
Biological Basis
Section titled “Biological Basis”Biologically, imidazole lactate is formed through the metabolism of histidine. While histidine is primarily catabolized to urocanic acid, it can also be converted to imidazolepyruvate, which is then reduced to imidazole lactate. The balance of these metabolic pathways can be influenced by various factors, including genetic variations. Measuring specific intermediate phenotypes, such as imidazole lactate, on a continuous scale provides a more detailed understanding of potentially affected biochemical pathways and their regulation[1].
Clinical Relevance
Section titled “Clinical Relevance”The clinical relevance of imidazole lactate stems from its potential as a biomarker for metabolic health and disease. Variations in its serum levels can reflect underlying genetic predispositions or environmental impacts on metabolic processes. Genome-wide association studies (GWAS) that integrate metabolite profiling, including imidazole lactate, aim to identify genetic variants associated with changes in the homeostasis of key metabolites. This approach can lead to a more nuanced understanding of disease mechanisms compared to focusing solely on overt clinical endpoints[1]. For instance, altered imidazole lactate levels could indicate disturbances in histidine metabolism, potentially linked to inherited metabolic disorders.
Social Importance
Section titled “Social Importance”From a societal perspective, the measurement and study of metabolites like imidazole lactate are crucial for advancing personalized healthcare. By combining an individual’s genetic profile with their metabolic characteristics, researchers hope to develop tailored health interventions and nutritional strategies[1]. This personalized approach could facilitate earlier detection of metabolic imbalances, improve risk assessment for various diseases, and lead to more effective prevention and management strategies, ultimately contributing to better public health outcomes.
Methodological and Statistical Considerations
Section titled “Methodological and Statistical Considerations”Initial genome-wide association studies (GWAS) often identify associations that, while statistically significant, may be subject to effect-size inflation, particularly when based on limited sample sizes [1]. For a specific metabolite like imidazole lactate, the robustness of identified genetic variants requires rigorous replication in independent and sufficiently powered cohorts to confirm their true effect and prevent false positives. Without extensive replication, the generalizability and clinical utility of these genetic associations remain uncertain, potentially leading to misinterpretations of their biological relevance. Furthermore, the composition of study cohorts can introduce bias, impacting the broader applicability of findings[1]. Factors such as age, sex, lifestyle, and underlying health conditions vary across populations, and if not adequately accounted for, can confound associations with imidazole lactate levels, potentially obscuring true genetic signals or inflating spurious ones.
Population Diversity and Phenotypic Assessment
Section titled “Population Diversity and Phenotypic Assessment”A significant limitation in understanding the genetic influences on imidazole lactate is the generalizability of findings across diverse ancestries. Most large-scale genetic studies on metabolite profiles have historically focused on populations of European descent[2], [3], [4]. This demographic imbalance limits the direct applicability of identified genetic variants for imidazole lactate to individuals from other ancestral backgrounds, where different genetic architectures or allele frequencies may exist. Consequently, the promise of personalized health care and nutrition based on these findings is currently restricted to a subset of the global population[1]. Beyond population considerations, the precise and consistent measurement of imidazole lactate is crucial for accurate genetic association studies. Variations in sample collection, storage, analytical platforms, and laboratory protocols can introduce significant noise or bias into metabolite quantification, potentially weakening genuine genetic signals or creating spurious associations.
Environmental Influences and Unexplained Variation
Section titled “Environmental Influences and Unexplained Variation”Imidazole lactate levels, like many intermediate phenotypes, are influenced not only by genetics but also by a complex interplay of environmental factors such as diet, lifestyle, medication, and the microbiome[5]. These environmental influences can act as confounders or interact with genetic predispositions, making it challenging to disentangle pure genetic effects from gene-environment interactions. Overlooking these complex interactions may lead to an incomplete understanding of the biological pathways regulating imidazole lactate and limit the utility of genetic markers for precise risk prediction. While GWAS can identify common genetic variants associated with traits, they often explain only a fraction of the observed phenotypic variance, a phenomenon known as “missing heritability”[6]. For imidazole lactate, a substantial portion of its heritability may remain unexplained by currently identified common variants, suggesting roles for rare variants, structural variations, epigenetic modifications, or complex polygenic interactions not fully captured by current methodologies.
Variants
Section titled “Variants”Genetic variations play a crucial role in influencing an individual’s metabolic profile, including the levels of specific metabolites like imidazole lactate. This section explores key genes and their variants that are associated with imidazole lactate or related metabolic pathways, offering insights into their potential impact.
Variants in genes involved in amino acid catabolism, such as HAL, KYAT3, and GOT2, are particularly relevant. The HAL (Histidine Ammonia-Lyase) gene, with variants like rs61937878 , encodes the primary enzyme responsible for initiating the breakdown of histidine. Impaired HALactivity can lead to an accumulation of histidine, which may then be shunted towards alternative metabolic pathways, including the formation of imidazole lactate. Similarly,KYAT3 (Kynurenine aminotransferase 3), with variants such as rs10801696 , rs1206228892 , rs7530513 , and rs74100109 (the latter also linked to RBMXL1), and GOT2 (Glutamic-oxaloacetic transaminase 2), including rs11076256 and rs1058192 , are aminotransferases. These enzymes facilitate the transfer of amino groups between amino acids and keto acids, playing broad roles in amino acid metabolism. Variations in these aminotransferases could indirectly affect imidazole lactate levels by altering the balance of various amino acid pools or the efficiency of transamination reactions, thereby influencing the metabolic flux through histidine pathways. Studies have identified genetic associations with diverse metabolic traits, including liver enzyme levels which reflect broader metabolic health[7], and general metabolite profiles in human serum [1].
The SLC6A13 (Solute Carrier Family 6 Member 13) gene, harboring variants rs10774021 , rs10774020 , and rs11613331 , encodes a gamma-aminobutyric acid (GABA) transporter, GAT-2. This transporter is expressed in various tissues, including the liver and kidneys, where it regulates GABA concentrations. Although GABA metabolism is distinct from histidine metabolism, the widespread expression of GAT-2 in metabolically active organs suggests a potential, albeit indirect, influence on overall metabolic homeostasis. Alterations in GABA transport could impact cellular energy metabolism or redox states, which might, in turn, affect the levels of a wide range of metabolites, including imidazole lactate. Research has highlighted genetic associations with kidney function and endocrine-related traits[8], as well as liver function [9], underscoring the broad metabolic impact of genes expressed in these critical organs.
Other variants reside in regions related to gene regulation and fundamental cellular processes. These include rs66609725 in the RNU6-1155P - RN7SL143P region, rs11643460 within GEMIN8P2 - RPL12P36, and rs11646417 in the RPL12P36 - Metazoa_SRP region, all of which are associated with pseudogenes or non-coding RNA elements that can influence gene expression. Additionally, the long non-coding RNA PKN2-AS1, with variant rs17433375 , can modulate the expression of the PKN2 gene, which is involved in various cellular signaling pathways. Variants like rs34554228 , rs4150678 , and rs4596 in GTF2H1 (General Transcription Factor IIH Subunit 1) affect a core component of the transcription machinery, thereby having widespread effects on gene expression. Similarly, RBMXL1 (RNA Binding Motif And X-Linked protein 1), associated with rs74100109 , is an RNA binding protein crucial for RNA processing. While these variants do not directly participate in histidine metabolism, their roles in global gene regulation, RNA processing, and cellular signaling can indirectly affect broad metabolic pathways and the overall metabolic state, potentially influencing the levels of various metabolites, including imidazole lactate. Genome-wide association studies consistently identify numerous loci impacting diverse metabolic phenotypes[10], reflecting the complex genetic architecture underlying metabolic traits.
Key Variants
Section titled “Key Variants”| RS ID | Gene | Related Traits |
|---|---|---|
| rs10801696 rs1206228892 rs7530513 | KYAT3 | imidazole lactate measurement |
| rs11076256 rs1058192 | GOT2 | X-13684 measurement Phenyllactate (PLA) measurement imidazole lactate measurement serum metabolite level aspartate aminotransferase measurement |
| rs66609725 | RNU6-1155P - RN7SL143P | X-11334 measurement imidazole lactate measurement indolelactate measurement Phenyllactate (PLA) measurement |
| rs10774021 rs10774020 rs11613331 | SLC6A13 | chronic kidney disease, serum creatinine amount serum creatinine amount, glomerular filtration rate BMI-adjusted waist circumference 1-methylimidazoleacetate measurement deoxycarnitine measurement |
| rs11643460 | GEMIN8P2 - RPL12P36 | indolelactate measurement imidazole lactate measurement |
| rs11646417 | RPL12P36 - Metazoa_SRP | imidazole lactate measurement urinary metabolite measurement |
| rs17433375 | PKN2-AS1 | imidazole lactate measurement body height |
| rs61937878 | HAL | vitamin D amount gamma-glutamylhistidine measurement histidine measurement imidazole lactate measurement N-acetylhistidine measurement |
| rs74100109 | KYAT3, RBMXL1 | imidazole lactate measurement |
| rs34554228 rs4150678 rs4596 | GTF2H1 | imidazole lactate measurement serum metabolite level 2-hydroxy-3-methylvalerate measurement |
Diagnosis
Section titled “Diagnosis”Quantitative Biochemical Profiling
Section titled “Quantitative Biochemical Profiling”Imidazole lactate is precisely quantified through targeted metabolite profiling using electrospray ionization (ESI) tandem mass spectrometry (MS/MS)[1]. This advanced biochemical assay is performed on specialized quantitative metabolomics platforms, ensuring high accuracy and reproducibility [1]. Serum samples undergo a rigorous preparation process involving coagulation, centrifugation, and immediate deep-freezing to preserve metabolite integrity before analysis [1]. The data obtained from these analyses is used directly without further correction, with quality control relying on internal standards and duplicates rather than phenotype information, enhancing objectivity [1].
Genetic and Pathway Insights
Section titled “Genetic and Pathway Insights”The assessment of imidazole lactate as an intermediate phenotype provides detailed insights into potentially affected metabolic pathways[1]. Genome-wide association studies (GWAS) integrate metabolomics data, including imidazole lactate levels, with genetic information to identify specific genetic variants influencing these metabolic profiles[1]. This approach allows for the discovery of molecular markers and genetic predispositions linked to an individual’s metabolic state, moving towards a more personalized understanding of health [1]. The continuous scale analysis of such phenotypes is expected to offer a more granular view of pathway perturbations compared to traditional broad phenotypic assessments [1].
Clinical Evaluation and Differential Diagnosis
Section titled “Clinical Evaluation and Differential Diagnosis”Clinical evaluation of imidazole lactate levels contributes to a comprehensive understanding of an individual’s metabolic status, particularly when integrated within broader metabolomics panels[1]. While specific diagnostic criteria for elevated or reduced imidazole lactate are not explicitly defined, its quantification helps in characterizing metabolic states and identifying deviations from normal physiological ranges[1]. This allows for distinguishing between various metabolic conditions or intermediate phenotypes by providing a continuous, objective measure of biochemical activity [1]. Such detailed metabolic characterization, combined with genotyping, supports the development of personalized health care strategies, potentially aiding in the differential diagnosis of complex metabolic disorders [1].
Biological Background of Imidazole Lactate
Section titled “Biological Background of Imidazole Lactate”Metabolites as Functional Readouts of Physiological State
Section titled “Metabolites as Functional Readouts of Physiological State”Metabolomics aims for the comprehensive measurement of endogenous metabolites found in various bodily fluids, including human serum. [1] These metabolite profiles provide a functional readout that reflects the intricate physiological state of an individual at a given time. [1]By characterizing the full spectrum of metabolites, researchers can gain deep insights into the dynamic biochemical processes, cellular functions, and regulatory networks that maintain health or contribute to disease. This approach is crucial for understanding the complex interplay of biological mechanisms within the human body.[1]
Genetic Influence on Metabolic Pathways
Section titled “Genetic Influence on Metabolic Pathways”Genetic mechanisms exert a significant influence on the homeostasis of essential biomolecules, such as various lipids, carbohydrates, and amino acids. [1] Genetic variants that associate with alterations in the levels or balance of these metabolites are expected to manifest as specific intermediate phenotypes on a continuous scale. [1] Such genetic associations offer a more detailed understanding of potentially affected molecular pathways and regulatory networks, which is vital for unraveling the underlying biological processes. [1] The integration of genetic information with comprehensive metabolic characterization represents a promising step towards personalized health care and nutrition strategies. [1]
Metabolomics in Understanding Pathophysiological Processes
Section titled “Metabolomics in Understanding Pathophysiological Processes”While traditional genome-wide association (GWA) studies often link genotypes to clinical outcomes, metabolomics offers a critical complementary approach by providing insights into the disease-causing mechanisms themselves.[1] By profiling metabolites, scientists can identify homeostatic disruptions and compensatory responses that characterize various pathophysiological processes. [1]This functional readout of the physiological state can illuminate how common diseases, such as diabetes, coronary artery disease, or rheumatoid arthritis, manifest at a biochemical level, even when the observed genetic effect sizes on clinical phenotypes are modest.[1]
Methodological Approaches for Metabolite Profiling
Section titled “Methodological Approaches for Metabolite Profiling”The accurate measurement of metabolites, including those present in human serum, relies on sophisticated analytical techniques. [1] For example, targeted metabolite profiling frequently utilizes electrospray ionization (ESI) tandem mass spectrometry (MS/MS) conducted on specialized quantitative metabolomics platforms. [1] The reliability of these measurements depends on meticulous sample preparation, which typically involves steps such as serum coagulation, centrifugation, aliquoting, and deep freezing. [1] These advanced methodologies enable the comprehensive and objectively quality-controlled assessment of metabolite levels, providing fundamental data for both genetic and physiological research. [1]
Based on the provided research context, there is no information available regarding the clinical relevance or measurement of ‘imidazole lactate’. Therefore, a “Clinical Relevance” section for this trait cannot be generated using the given sources.
Frequently Asked Questions About Imidazole Lactate Measurement
Section titled “Frequently Asked Questions About Imidazole Lactate Measurement”These questions address the most important and specific aspects of imidazole lactate measurement based on current genetic research.
1. Why do I feel tired after certain foods, while my friend doesn’t?
Section titled “1. Why do I feel tired after certain foods, while my friend doesn’t?”Your body’s unique metabolism, influenced by your genetics and lifestyle, determines how you process different foods. Metabolites like imidazole lactate, which comes from amino acid breakdown, can reflect these individual differences. Variations in genes involved in amino acid metabolism mean some people process nutrients differently, leading to varied energy responses. Understanding your specific metabolic profile could help tailor your diet for better energy.
2. My family has a history of metabolic issues. Am I destined to get them too?
Section titled “2. My family has a history of metabolic issues. Am I destined to get them too?”Not necessarily. While genetic predispositions play a significant role, your genes aren’t your full destiny. Metabolites like imidazole lactate can reflect these predispositions, but environmental factors like diet, lifestyle, and even medication also heavily influence your metabolic health. Understanding your unique genetic and metabolic profile can help you make targeted lifestyle changes to potentially mitigate risks.
3. Does what I eat really change my body differently than others?
Section titled “3. Does what I eat really change my body differently than others?”Absolutely. Your individual genetic makeup interacts with your diet, leading to unique metabolic responses. For example, how your body processes amino acids, which impacts levels of metabolites like imidazole lactate, can vary due to genetic differences. This is why a diet that works well for one person might not be optimal for another.
4. Can stress or lack of sleep mess up my body’s chemistry in real ways?
Section titled “4. Can stress or lack of sleep mess up my body’s chemistry in real ways?”Yes, definitely. Environmental factors like stress, sleep patterns, and lifestyle choices profoundly impact your metabolic processes. These influences can alter the balance of various metabolites in your body, including those involved in amino acid breakdown like imidazole lactate. Such changes can reflect underlying metabolic imbalances, even if they’re not solely genetic.
5. I’m not of European descent; does that mean health studies don’t apply to me?
Section titled “5. I’m not of European descent; does that mean health studies don’t apply to me?”It’s a valid concern. Many large genetic studies on metabolites, including those looking at markers like imidazole lactate, have historically focused on populations of European descent. This means findings might not directly apply to individuals from other ancestral backgrounds, where different genetic variations and frequencies can exist. More diverse research is crucial for truly personalized healthcare for everyone.
6. If I get a health test, will it actually tell me how to eat better?
Section titled “6. If I get a health test, will it actually tell me how to eat better?”A comprehensive health test that includes metabolic profiling, like measuring imidazole lactate, can offer valuable insights. By combining your genetic profile with your metabolic characteristics, researchers hope to develop more personalized nutritional strategies. This could help you understand how your body processes specific nutrients and guide you toward more effective dietary choices.
7. Why do some diets work for my friends but not for me?
Section titled “7. Why do some diets work for my friends but not for me?”Individual metabolic differences, influenced by your genetics and environment, are a key reason. Your body’s specific pathways for processing nutrients, which can be reflected in metabolites like imidazole lactate, vary from person to person. This means a diet optimized for one person’s metabolism might not align with another’s, highlighting the need for personalized approaches.
8. Does aging make my metabolism less efficient, no matter what I do?
Section titled “8. Does aging make my metabolism less efficient, no matter what I do?”Aging can certainly influence metabolic processes, and it’s a factor that can affect metabolite levels, including imidazole lactate. While genetics play a role in how your body ages metabolically, lifestyle choices like diet and exercise can significantly impact metabolic efficiency. It’s a complex interplay where age is one of many factors.
9. Could my gut bacteria affect my overall health in surprising ways?
Section titled “9. Could my gut bacteria affect my overall health in surprising ways?”Absolutely, your gut microbiome plays a significant role in your overall health and metabolism. The bacteria in your gut can influence how you process nutrients and even interact with your genetic predispositions. This complex interplay can affect levels of various metabolites, like imidazole lactate, making your microbiome a crucial environmental factor.
10. If a test shows something “off” with my metabolism, can I fix it with lifestyle changes?
Section titled “10. If a test shows something “off” with my metabolism, can I fix it with lifestyle changes?”Often, yes. While some metabolic variations have a strong genetic basis, many are significantly influenced by lifestyle. If a test reveals imbalances in metabolites like imidazole lactate, targeted interventions through diet, exercise, and other lifestyle adjustments can often help improve your metabolic health. It empowers you to take proactive steps.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
Section titled “References”[1] Gieger, C., et al. “Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum.” PLoS Genet, vol. 4, no. 11, 2008, e1000282.
[2] Kathiresan, S., et al. “Common variants at 30 loci contribute to polygenic dyslipidemia.” Nature Genetics, vol. 40, no. 2, 2008, pp. 189-97.
[3] Aulchenko, Y. S., et al. “Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts.”Nature Genetics, vol. 40, no. 1, 2008, pp. 119-26.
[4] Sabatti, C., et al. “Genome-wide association analysis of metabolic traits in a birth cohort from a founder population.” Nature Genetics, vol. 40, no. 12, 2008, pp. 1394-402.
[5] Ridker, P. M., et al. “Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women’s Genome Health Study.” American Journal of Human Genetics, vol. 82, no. 5, 2008, pp. 1185-92.
[6] Benyamin, B., et al. “Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels.” American Journal of Human Genetics, vol. 84, no. 1, 2009, pp. 60-65.
[7] Yuan, X., et al. “Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes.” Am J Hum Genet, vol. 83, no. 4, 2008, pp. 520-528.
[8] Hwang, S. J., et al. “A genome-wide association for kidney function and endocrine-related traits in the NHLBI’s Framingham Heart Study.” BMC Med Genet, vol. 8, suppl. 1, 2007, p. S10.
[9] Benjamin, E. J., et al. “Genome-wide association with select biomarker traits in the Framingham Heart Study.” BMC Med Genet, vol. 8, suppl. 1, 2007, p. S9.
[10] Sabatti, C., et al. “Genome-wide association analysis of metabolic traits in a birth cohort from a founder population.” Nat Genet, vol. 41, no. 1, 2009, pp. 35-42.